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Aims Current criteria for cardiac resynchronization therapy (CRT) are restricted to patients with a wide QRS complex
(.120 ms). Overall, only 30% of heart failure patients demonstrate a wide QRS complex, leaving the majority of
heart failure patients without this treatment option. However, patients with a narrow QRS complex exhibit left ven-
tricular (LV) mechanical dyssynchrony, as assessed with echocardiography. To further elucidate the possible beneficial
effect of CRT in heart failure patients with a narrow QRS complex, this two-centre, non-randomized observational
study focused on different echocardiographic parameters of LV mechanical dyssynchrony reflecting atrioventricular,
interventricular and intraventricular dyssynchrony, and the response to CRT in these patients.
Methods and
results
A total of 123 consecutive heart failure patients with a narrowQRS complex (,120 ms) undergoing CRTwas included
at two centres. Several widely accepted measures of mechanical dyssynchrony were evaluated: LV filling ratio (LVFT/
RR), LV pre-ejection time (LPEI), interventricular mechanical dyssynchrony (IVMD), opposing wall delay (OWD), and
anteroseptal posterior wall delay with speckle tracking (ASPWD). Response to CRT was defined as a reduction ≥15%
in left ventricular end-systolic volume at 6 months follow-up. Measures of dyssynchrony can frequently be observed in
patients with a narrow QRS complex. Nonetheless, for LVFT/RR, LPEI, and IVMD, presence of predefined significant
dyssynchrony is,20%. Significant intraventricular dyssynchrony is more widely observed in these patients. With recei-
ver operator characteristic curve analyses, both OWD and ASPWD demonstrated usefulness in predicting response to
CRT in narrow QRS patients with a cut-off value of 75 and 107 ms, respectively.
Conclusion Mechanical dyssynchrony can be widely observed in heart failure patients with a narrow QRS complex. In particular,
intraventricular measures of mechanical dyssynchrony may be useful in predicting LV reverse remodelling at 6 months
follow-up in heart failure patients with a narrow QRS complex, but with more stringent cut-off values than currently
used in ‘wide’ QRS patients.
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Introduction
Cardiac resynchronization therapy (CRT) is an established treat-
ment for patients with severe symptomatic heart failure, depressed
left ventricular ejection fraction (LVEF) and QRS complex
≥120 ms.1 Several studies demonstrated that heart failure patients
with depressed LVEF but a narrow QRS complex have mechanical
dyssynchrony, as assessed with echocardiography.2–4 Previous
single-centre studies of CRT in patients with narrow QRS
complex and mechanical dyssynchrony have suggested a thera-
peutic benefit.4–7 However, the results of the first randomized
trial of CRT in heart failure patients with QRS complexes
(,130 ms) by Beshai et al.8 were equivocal. RethinQ could not
demonstrate conclusive evidence to support CRT in narrow
QRS patients by its primary endpoint of peak myocardial oxygen
consumption. Notwithstanding, patients randomized to CRT
demonstrated significant improvement in the New York Heart
Association (NYHA) functional class and showed a trend toward
lower heart failure event rates compared with control patients;
the potential benefits of CRT for patients with a narrow QRS
complex remain still elusive. As such, the objectives of the
current study were to test the hypotheses that CRT may be associ-
ated with favourable LV reverse remodelling in patients with a
narrow QRS duration, and that specific echocardiographic
markers of dyssynchrony may predict LV functional response in a
two-centre, non-randomized observational study.
Methods
Study population and protocol
A total of 123 consecutive patients with a QRS duration ,120 ms,
referred for echocardiographic dyssynchrony study prior to CRT
were included at two centres (34 patients in Pittsburgh and 89 in
Leiden). All patients were in NYHA class III and had a LVEF ≤ 35%.
Patients were not part of a clinical trial, but were referred for CRT
implantation, due to severe systolic heart failure with no other remain-
ing treatment options. Before CRT implantation, all patients under-
went extensive evaluation of clinical status as well as transthoracic
echocardiography. Clinical evaluation included the assessment of
NYHA functional class, quality-of-life score (according to Minnesota
Living With Heart Failure Questionnaire)9 and 6 min walking test.10
Echocardiography
All patients underwent echocardiography in the left lateral decubitus
position before and 6 months after CRT implantation. Studies were
performed using a commercially available echocardiographic system
(VIVID 7, General Electric Vingmed Ultrasound, Milwaukee, WI,
USA). Images were obtained using a 3.5 MHz transducer, at a depth
of 16 cm in the parasternal (long- and short-axis) and apical views
(long-axis, two- and four-chamber images). Standard two-dimensional
(2D) and colour Doppler data, triggered to the QRS complex, were
saved in a cineloop format. A minimum of three consecutive beats
were recorded from each view and the images were digitally stored
for off-line analysis (EchoPac 7.0.0, General Electric Vingmed Ultra-
sound). Sector width was optimized to allow for complete myocardial
visualization while maximizing frame rate. Gain settings were adjusted
for routine clinical greyscale 2D images to optimize endocardial
definition. For speckle tracking analysis, standard 2D greyscale
images were acquired at a mean frame rate of 65+ 15 frames/s
(range 30–100 frames/s). In addition, colour coded tissue Doppler
imaging (TDI) was performed at a frame rate .80 frames/s in all sub-
jects and aliasing velocity was 16–32 cm/s. Left ventricular end-systolic
volume (LVESV), left ventricular end-diastolic volume (LVEDV), and
LVEF were measured from the apical two- and four-chamber images,
using the modified biplane Simpson’s rule.11 Response to CRT was
defined as a reduction ≥15% in LVESV at 6 months follow-up.12,13
Dyssynchrony measurements
A comprehensive assessment of cardiac dyssynchrony was performed,
comprising the analysis of atrioventricular, inter- and intraventricular
dyssynchrony.
Atrioventricular dyssynchrony analysis
To assess atrioventricular dyssynchrony, recordings of transmitral flow
with pulsed-wave Doppler were used.14 Diastolic filling time was
defined as the sum of E-wave + A-wave duration (LVFT). This diastolic
filling time was then divided by the RR interval (Figure 1A). A diastolic
filling ratio (LVFT/RR) ,40% was considered to represent significant
atrioventricular dyssynchrony.15
Interventricular dyssynchrony analysis
Two parameters were measured to evaluate interventricular dyssyn-
chrony: the left pre-ejection interval (LPEI) and the interventricular
mechanical delay (IVMD). The LPEI was obtained using standard
pulsed-wave Doppler echocardiography on the apical long-axis view,
measuring the time from onset of the QRS complex to onset of
aortic flow (Figure 1B). The previously proposed cut-off value of
140 ms was used to define a prolonged delay.15 To calculate the
IVMD, time from onset of the QRS to onset of pulmonary flow was
measured at the parasternal short-axis view, using pulsed-wave
Doppler. The difference between these two values resulted in the
IVMD16 (Figure 1C). On the basis of previous work, an IVMD
.40 ms represented significant delay.15,17
Intraventricular dyssynchrony analysis
The intraventricular dyssynchrony was evaluated by TDI derived longi-
tudinal dyssynchrony and speckle tracking 2D radial strain dyssyn-
chrony. For assessment of longitudinal LV dyssynchrony, TDI was
performed using the apical two- and four-chamber views. Regions of
interest were placed in the basal portions of the anterior, inferior,
septal, and lateral segments.13 For all patient studies, regions of interest
were manually adjusted within the segment in the longitudinal plane of
the LV and within the wall to identify the most reproducible peak vel-
ocity during LV ejection. Systolic peaks after aortic valve closure were
not included. Dyssynchrony by TDI was determined as a minimum
time difference in peak systolic velocities ≥65 ms between any two
opposing wall delay (OWD)13 (Figure 1D).
For assessment of radial dyssynchrony, speckle tracking analysis of
routine greyscale mid LV short-axis images was performed as pre-
viously described.18 In brief, an end-systolic circular region of interest
was manually traced on the endocardial-border (minimum cavity area).
The software then automatically created a second larger circle at the
epicardial level, such that the region of interest spans the LV myocar-
dium. The width of this automatically created region of interest could
be adjusted manually by the operator, depending on the thickness of
the LV wall. Speckle tracking automatically analysed frame-by-frame
movement of the stable acoustic markers distributed within the myo-
cardial wall, or speckles, over the cardiac cycle.18,19 From this
frame-by-frame movement, it calculated regional strain vectors as
change in length/initial length, with myocardial thickening toward the
LV centre represented as a positive value. Next, the traced
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endocardium was automatically divided into six standard segments:
septal, anteroseptal, anterior, lateral, posterior, and inferior. Finally,
corresponding time-strain curves for all six segments were con-
structed. Significant radial dyssynchrony was defined as the time differ-
ence between the anteroseptal and posterior wall segmental peak
strain (ASPWD) ≥130 ms18 (Figure 1E).
Device implantation
The LV lead was inserted transvenously via the subclavian route.
A coronary sinus venogram was obtained using a balloon catheter.
Next, the LV pacing lead was inserted through the coronary sinus
with an 8Fr guiding catheter and positioned as far as possible in the
venous system, preferably in a (postero-) lateral vein. The right atrial
and ventricular leads were positioned conventionally, and all leads
were connected to a dual-chamber biventricular implantable cardiac
device. When an indication for internal defibrillator existed, a com-
bined CRT-D device was used. Simultaneous biventricular pacing
was applied without exception for the first 6 months. The pro-
grammed atrioventricular delays ranged from 100 to 130 ms.
Statistical analysis
Continuous data are presented as mean+SD and dichotomous data are
presented as numbers and percentages. Comparison of data between
patient groups was performed using the independent-samples t-test for
continuous data. Data for LVEDV, LVESV, QRS duration, IVMD and
ASPWD were not normally distributed (as evaluated by Kolmogorov–
Smirnov tests) and therefore presented as medians and corresponding
25th and 75th percentiles. Consequently, comparison of these data
among patient groups was performed with the Mann–Whitney U test.
Fisher’s exact tests orx2 testswereusedas appropriate to comparedichot-
omous data. Comparison of datawithin patient groups (at baseline and at 6
months follow-up) was performed with the paired-samples t-test. Com-
parison of data for LVEDV, LVESV, QRS duration, IVMD, and ASPWD
within patient groups was performed with the Wilcoxon test. Receiver
operator characteristic (ROC) curves were constructed for different dys-
synchrony measurements to determine the optimal cut-off value. An
optimal cut-off value was defined as the value that yielded the highest
sum of sensitivity and specificity. All analyses were performed with SPSS
for Windows, version 16.0 (SPSS, Chicago, IL, USA). All statistical tests
were two-sided. A P-value of,0.05was considered statistically significant.
Figure 1 (A) Example of left ventricular filling ratio (LVFT/RR). LVFT/RR in this patient is 67%. (B) Example of left pre-ejection interval (LPEI).
LPEI in this patient is 109 ms. (C) Example of interventricular mechanical delay (IVMD). IVMD in this patient is 48 ms. (D) Example of opposing
wall delay (OWD). OWD in this patient exists between the septum and the lateral wall and is 140 ms. (E) Example of anteroseptal to posterior
wall delay (ASPWD). ASPWD in this patient is 125 ms.
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Results
Patient characteristics
A total of 123 patients were included; baseline characteristics of
these patients are summarized in Table 1. All patients were in
NYHA functional class III and had enlarged LV volumes with
severely depressed LV function (mean LVEF 27+7%). Medication
included diuretics in 94%, angiotensin-converting enzyme-
inhibitors in 90% and beta-blockers in 93%. All medication was
continued after CRT implantation. According to the study proto-
col, all subjects had QRS duration ,120 ms with a mean of
105+10 ms.
Dyssynchrony measurements
Atrioventricular dyssynchrony analysis was feasible in 118 patients
(96%) and resulted in a mean LVFT/RR of 52+7%. Only four
patients (3%) met the predefined cut-off value for significantly
reduced LVFT/RR ,40%.
Figure 1 (Continued)
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For IVMD, two measurements were performed; LPEI and IVMD.
Measurement of LPEI could be achieved in 119 patients (97%).
Mean LPEI in the study population was 121+20 ms, with 20
patients (17%) meeting a significant value .140 ms. Second,
IVMD analysis was successfully performed in 110 subjects (89%)
and the mean value for IVMD was 18+ 14 ms. Seven patients
(6%) demonstrated a prolonged IVMD .40 ms.
Finally, intraventricular dyssynchrony was assessed in the longitudi-
nal and radial directions. Opposing wall delay, as measured with TDI,
was feasible in 120 patients (98%) and resulted in a mean OWD of
81+38 ms. In 77 patients (66%), significant OWD ≥ 65 ms was
observed. For radial dyssynchrony, speckle tracking analysis was per-
formedon standard short-axis images of the left ventricle. The analysis
was feasible in 111 patients (90%) and mean radial dyssynchrony was
128+99 ms. Forty-three patients (39%) had an ASPWD ≥ 130 ms
(Figure 2). Of note, patients with a QRS duration .100 ms had an
overall larger extent of dyssynchrony than patients with a QRS dur-
ation ≤100 ms (Table 2).
Cardiac resynchronization therapy
responders vs. non-responders
At follow-up, 89 (72%) patients had a reduction in NHYA func-
tional class. Moreover, LVEDV decreased from 201+64 to
189+64 mL (P ¼ 0.001) and a similar decrease from 147+ 52
to 130+ 55 mL (P, 0.001) was observed for LVESV. Left ventri-
cular ejection fraction increased from 27+7 to 33+ 10% (P,
0.001). Fifty-nine patients (48%) showed response to CRT,
defined as a reduction of ≥15% in LVESV. There were no differ-
ences in baseline clinical characteristics between responders and
non-responders (Table 3). In addition, baseline LV volumes and
LVEF were comparable between the two groups of patients;
however, responders demonstrated a larger extent of IVMD,
OWD, and ASPWD at baseline than non-responders. Of note,
only 7 (12%) responders had no dyssynchrony by any predefined
cut-off vs. 24 (38%) non-responders (P ¼ 0.003). Finally, more dys-
synchrony was observed in patients with a QRS duration .100 ms
when compared with patients with a QRS duration ≤100 ms
(Table 2). However, this did not result in a significantly higher
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Table 1 Patient characteristics (n 5 123)
Age (years) 61+11
Men/women 97/26
Aetiology (n)
Ischaemic 75 (61%)
Non-ischaemic 48 (39%)
NYHA class III 123 (100%)
6 MWT (m) 310+100
QoL score 34+19
QRS duration (ms), 25th–75th percentiles 106 (98–114)
PR interval (ms) 176+28
Medication (n)
Diuretics 116 (94%)
ACE-inhibitors/AII-blocker 111 (90%)
Beta-blockers 114 (93%)
Spironolactone 75 (61%)
LVEDV (mL), 25th–75th percentiles 189 (155–237)
LVESV (mL), 25th–75th percentiles 141 (110–176)
LVEF (%) 27+7
LVFT/RR (%) 52+7
LPEI (ms) 121+20
IVMD (ms), 25th–75th percentiles 16 (7–28)
OWD (ms) 81+38
ASPWD (ms), 25th–75th percentiles 107 (57–179)
6 MWT, 6 minute walk test; ACE, angiotensin-converting enzyme; ASPWD,
anteroseptal to posterior wall delay; IVMD, interventricular mechanical delay;
LPEI, left pre-ejection interval; LVEDV, left ventricular end-diastolic volume; LVEF,
left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; LVFT/
RR, left ventricular filling ratio; NYHA, New York Heart Association; OWD,
opposing wall delay; QoL, quality of life.
Figure 2 Presence of predefined dyssynchrony measures in
patients with a narrow QRS complex. ASPWD, anteroseptal to
posterior wall delay; IVMD, interventricular mechanical delay;
LPEI, left pre-ejection interval; LVEDV, left ventricular end-
diastolic volume; LVEF, left ventricular ejection fraction; LVESV,
left ventricular end-systolic volume; LVFT/RR, left ventricular
filling ratio; OWD, opposing wall delay.
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Table 2 Baseline dyssynchrony parameters in patients
with a QRS duration >100 ms and patients with a QRS
duration ≤100 ms
Variable QRS duration
≤100 ms
(n5 41)
QRS duration
>100 ms
(n5 82)
P-value
LVFT/RR (%) 51+7 53+7 0.156
LPEI (ms) 115+21 124+20 0.022
IVMD (ms),
25th–75th
percentiles
15 (4–25) 17 (9–30) 0.081
OWD (ms) 67+37 87+37 0.007
ASPWD (ms),
25th–75th
percentiles
75 (43–121) 122 (66–187) 0.024
Bold indicates statistical significance P, 0.05.
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response rate. In patients with a QRS duration .100 ms, 42 (51%)
showed response, compared with 17 (41%) patients with a QRS
duration ≤100 ms (P ¼ 0.307).
Dyssynchrony and response to cardiac
resynchronization therapy
Receiver operator characteristic curve analyses were performed to
investigate whether other cut-off values for this population (when
compared with patients with a wide QRS complex) are more suit-
able to predict response to CRT. Since the predefined cut-off
values for LVFT/RR, LPEI, and IVMD were only sporadically met,
no ROC curve analyses for these measures of dyssynchrony
were performed. The ROC curves for the intraventricular
measures of dyssynchrony (OWD and ASPWD) are provided in
Figure 3A and B. Receiver operator characteristic curve analysis
for TDI derived OWD demonstrated an optimal cut-off value of
75 ms, with a sensitivity of 70.7% and specificity of 56.5%
(Figure 3A). The positive predictive value (PPV) for a cut-off of
75 ms was 70%. Conversely, a cut-off value of 83 ms yielded a sen-
sitivity of 55.4% and a specificity of 65%. The sensitivity and speci-
ficity for the predefined cut-off value of 65 ms were 76.8 and
48.3%, respectively. For ASPWD, assessed with speckle tracking
imaging, a cut-off value of 107 ms resulted in a sensitivity of
70.9% and a specificity of 75.0% (Figure 3B), and predicted
response to CRT with a PPV of 71%. The sensitivity and specificity
for the predefined cut-off value of 130 ms were 56.4 and 78.6%,
respectively.
Discussion
The findings in the current study can be summarized as follows;
mechanical dyssynchrony is often present in heart failure patients
with a narrow QRS complex; atrioventricular and interventricular
mechanical dyssynchrony are less frequently noted, while intraven-
tricular dyssynchrony is frequently observed; and finally, intraven-
tricular measures of mechanical dyssynchrony may be useful in
predicting LV reverse remodelling at 6 months follow-up in heart
failure patients with a narrow QRS complex.
Cardiac resynchronization therapy and
mechanical dyssynchrony
Although CRT is nowadays considered a class I indication in heart
failure patients in NYHA functional class III or IV, a LVEF ≤35%
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Table 3 Patient characteristics in cardiac resynchronization therapy responders and non-responders
Variable Responders (n 5 59) Non-responders (n 5 64) P-value
Age (years) 61+11 60+12 0.618
Men/Women 44/15 53/11 0.279
Aetiology (n) 0.095
Ischaemic 31 (53%) 44 (69%)
Non-ischaemic 28 (47%) 20 (31%)
QRS duration (ms), 25th–75th percentiles 106 (100–112) 106 (98–114) 0.847
Follow-up 128 (112–148) 140 (120–154) 0.217
Medication (n)
Diuretics 55 (93%) 61 (95%) 0.709
ACE-inhibitors/AII-blocker 54 (92%) 57 (89%) 0.765
Beta-blockers 57 (97%) 57 (89%) 0.167
Spironolactone 33 (56%) 42 (66%) 0.355
LVEDV (mL), 25th–75th percentiles 195 (160–246) 188 (152–231) 0.199
Follow-up 157 (127–199) 208 (160–247) <0.001
LVESV (mL), 25th–75th percentiles 154 (113–182) 139 (103–167) 0.125
Follow-up 98 (74–136) 151 (113–186) <0.001
LVEF (%) 26+7 28+8 0.250
Follow-up 38+9 28+8 <0.001
LVFT/RR (%) 53+8 51+7 0.142
LPEI (ms) 123+22 119+19 0.344
IVMD (ms), 25th–75th percentiles 23 (9–33) 13 (6–21) 0.013
OWD (ms) 92+39 70+35 0.002
ASPWD (ms), 25th–75th percentiles 146 (100–200) 68 (36–110) <0.001
ACE, angiotensin-converting enzyme; ASPWD, anteroseptal to posterior wall delay; IVMD, interventricular mechanical delay; LPEI, left pre-ejection interval; LVEDV, left
ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; LVFT/RR, left ventricular filling ratio; OWD, opposing wall
delay.
Bold indicates statistical significance P, 0.05.
Dyssynchrony and CRT in narrow QRS 3059
and a QRS duration ≥120 ms,1 nearly 30% of patients do not
improve in clinical symptoms and 40–50% do not show signifi-
cant LV reverse remodelling after CRT. To optimize patient selec-
tion for CRT and to improve outcome after CRT, the use of
echocardiographic measures of mechanical dyssynchrony has
been proposed to better identify potential responders to
CRT.13,15,20–23 Underlying this search for better predictors of
response were two vital assumptions: first, evidence of electrocar-
diographic dyssynchrony (QRS widening) is not always correlated
to mechanical dyssynchrony, and second, restoring (mechanical)
synchrony within the LV is the key mechanism that allows benefit
from CRT. Heart failure patients with a narrow QRS complex
can also exhibit LV mechanical dyssynchrony, as demonstrated by
many studies using echocardiography.2,3,24 Others have also con-
firmed that restoring synchrony within the LV (‘resynchronization’)
is mandatory for response to CRT.25 From that time, echocardio-
graphic markers of baseline mechanical dyssynchrony have been
used in identifying potential favourable responders before CRT
implantation.13,15,20–23
Efficacy of cardiac resynchronization
therapy in patients with a ‘narrow’
QRS complex
Since the use of echocardiographic markers of dyssynchrony in
patients with a wide QRS complex has become more widespread,
the above mentioned assumptions were extended to patients with
a ‘narrow’ QRS complex (,120 ms), as these patients can also
exhibit mechanical dyssynchrony as a substrate for CRT.4–7,26
Achilli et al.6 were among the first to investigate the effects of
CRT in heart failure patients with a narrow QRS complex. The
authors studied 14 ‘narrow’ QRS (≤120 ms) patients with
evidence of mechanical dyssynchrony before CRT implantation
and compared the clinical and echocardiographic changes at
6 months follow-up with 38 ‘wide’ QRS patients. The patients in
the narrow QRS group showed improvement in all clinical end-
points: NYHA functional class improved from 3.3+ 0.5 to 1.7+
0.6 (P, 0.001) and distance covered in the 6 min walking test
increased from 276+ 89 to 370+70 m (P, 0.001). More impor-
tantly, a significant reduction in LV diameters (LV end-diastolic
diameter decreased from 72+ 9 to 66+9 mm and LV end-
systolic diameter decreased from 61+ 8 to 56+ 8 mm, P,
0.05 for both) was observed at 6 months follow-up. Finally, LVEF
increased from 24.6+5.0% at baseline to 33.6+ 5.9% (P,
0.001), indicating improvement in LV systolic function.
Another study by Bleeker et al.5 evaluated the effects of CRT in
33 patients with a narrow QRS complex with significant LV dyssyn-
chrony (septal to lateral delay ≥65 ms with TDI). At 6 months
follow-up, patients improved in heart failure symptoms
(NYHA functional class decreased from 3.1+0.3 to 2.0+ 0.6,
P, 0.001) and also demonstrated marked LV reverse remodelling
(LVESV decreased from 189+ 60 to 144+58 mL and LVEDV
decreased from 238+ 72 to 203+66 mL, P, 0.001 for both).
A more recent study from Cazeau et al. (DESIRE) focused on
the effect of pre-implantation LV dyssynchrony in a large cohort
of patients with narrow and intermediate (120–150 ms) QRS
complexes treated with CRT, rather than pre-selecting narrow
QRS patients that demonstrated significant dyssynchrony and com-
paring them with wide QRS patients.7 The authors included a total
of 60 patients in NYHA class III, with a mean LVEF of 25.7% and a
QRS duration of 121+191 ms. Patients were divided into two
groups: one group of 27 patients that had ≥1 predefined echo cri-
terion of mechanical dyssynchrony (DES+) and one group of 33
patients without dyssynchrony (DES2). Improvement in the
primary endpoint (a combination of all-cause mortality, heart
failure hospitalizations and NYHA functional class at 6 months
follow-up) was observed in 19 of 27 DES+ patients (70%) vs. 14
of 33 DES2 patients (42%), P, 0.04. This particular study used
only conventional parameters of dyssynchrony (e.g. diastolic
filling ratio, LPEI, and IVMD), which may explain that only 27
Figure 3 Receiver operator characteristic curve analyses for predicting reduction in LVESV ≥15% after CRT for: opposing wall delay using
TDI (OWD, A) and anteroseptal to posterior wall delay using speckle tracking (ASPWD, B).
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(45%) patients met the ≥1 predefined criterion. Although exact
frequencies per positive criterion are not reported, it seems that
(like in the present study) IVMD was rarely observed. Finally,
mean QRS duration in the DESIRE study was higher, hampering
exact comparison between reported results. Nonetheless, the
results from DESIRE clearly demonstrate that narrow QRS patients
with documented evidence of mechanical dyssynchrony derive
greater benefit from CRT than narrow QRS patients without
mechanical dyssynchrony.
Results from RethinQ and future
perspectives
Thriving on the promising results of many of these smaller studies,
a small pilot clinical trial on the effect of CRT in heart failure
patients with a narrow QRS complex was performed.8 The Resyn-
chronization therapy in narrow QRS (RethinQ) study included 172
patients with a narrow QRS complex and documented echocar-
diographic evidence of mechanical dyssynchrony, defined as
either septal to posterior wall motion delay ≥130 ms using
M-Mode, or septal to LV free wall (lateral or posterior) delay
≥65 ms using TDI. Patients were randomized to a CRT ON and
a CRT OFF group. The study could not demonstrate a significant
difference in the primary endpoint (increase in peak oxygen con-
sumption ≥1.0 mL per kilogram of body weight per minute
during exercise testing at 6 months) between the CRT ON and
the CRT OFF group.
On the other hand, there was a significant difference in change in
NHYA class (54% improved in the CRT ON group vs. 29% in the
CRT OFF group, P ¼ 0.006) and a trend towards reduction of heart
failure events in the CRT group (22.3 vs. 16.1%, respectively).
Although these inconsistencies between the respective end-
points are remarkable and indicative for the currently ongoing
quest for clinically relevant endpoints in CRT research, it further
underscores the need to base clinical decision-making on hard
clinical morbidity and mortality endpoints rather than volumetric
remodelling alone, for which a uniform definition is still lacking.
Next to improvement in clinical symptoms and/or improvement
in LV systolic function, also ‘no worsening/non-progressing’ has
been proposed as measure of success of CRT.27,28 The rationale
for such an endpoint is that heart failure is a progressive disease,
and attenuation of the natural course (worsening) should also be
considered as positive response. Clearly, the best endpoint to
assess success of a certain heart failure treatment (CRT in this
case) is a benefit on all-cause mortality and/or cause-specific hos-
pitalizations.29 Currently there is a large randomized clinical trial
ongoing to address that very issue in narrow QRS patients under-
going CRT. EchoCRT is designed to investigate the reduction in all-
cause mortality or first hospitalization for worsening heart failure
during a follow-up of at least 24 months in .1200 heart failure
patients with a narrow QRS complex, but evidence of mechanical
dyssynchrony.30 Moreover, this will be the first clinical trial to use
the newly proposed speckle tracking technique for evaluation of
mechanical dyssynchrony. In many single centre studies, this
method proved to be superior for dyssynchrony assessment and
had a higher predictive value for CRT response than more conven-
tional echocardiographic measures.18,31,32 The technique is not
affected by insonation angle and has the advantage that it
permits discrimination between active deformation and passive
motion of the myocardium. Therefore, it may be the preferred
method to assess dyssynchrony in patients with ischaemic heart
disease and areas of scar tissue. Also, in the current study,
speckle tracking had the highest diagnostic accuracy for predicting
LV reverse remodelling at 6 months follow-up. Possibly, EchoCRT
will provide the answer for the effectiveness of CRT in patients
with a narrow QRS complex and echocardiographic evidence of
mechanical dyssynchrony.
Conclusion and clinical implications
The present study suggests a beneficial effect of CRT on LV
volumes and systolic function in heart failure patients with a
narrow QRS complex, but with evidence of mechanical dyssyn-
chrony as assessed by echocardiography. Accordingly, patients
with drug-refractory heart failure and a narrow QRS complex,
but mechanical dyssynchrony could be considered candidates for
CRT. The main focus on identifying potential responders to CRT
using echocardiography should be on measures of intraventricular
dyssynchrony, rather than atrioventricular or interventricular dys-
synchrony. Nevertheless, until the final results of EchoCRT, a clini-
cal value and potential benefit from CRT in heart failure patients
with a narrow QRS complex and mechanical dyssynchrony
remains currently unclear.
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